ATE479761T1 - Expression biologisch aktiver polypeptide in wasserlinse - Google Patents

Expression biologisch aktiver polypeptide in wasserlinse

Info

Publication number
ATE479761T1
ATE479761T1 AT01967946T AT01967946T ATE479761T1 AT E479761 T1 ATE479761 T1 AT E479761T1 AT 01967946 T AT01967946 T AT 01967946T AT 01967946 T AT01967946 T AT 01967946T AT E479761 T1 ATE479761 T1 AT E479761T1
Authority
AT
Austria
Prior art keywords
duckweed
expression
biologically active
active polypeptides
polypeptide
Prior art date
Application number
AT01967946T
Other languages
English (en)
Inventor
Anne-Marie Stomp
Lynn Dickey
John Gasdaska
Original Assignee
Biolex Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolex Therapeutics Inc filed Critical Biolex Therapeutics Inc
Application granted granted Critical
Publication of ATE479761T1 publication Critical patent/ATE479761T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT01967946T 2000-07-31 2001-07-26 Expression biologisch aktiver polypeptide in wasserlinse ATE479761T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22170500P 2000-07-31 2000-07-31
US29333001P 2001-05-23 2001-05-23
PCT/US2001/023400 WO2002010414A2 (en) 2000-07-31 2001-07-26 Expression of biologically active polypeptides in duckweed

Publications (1)

Publication Number Publication Date
ATE479761T1 true ATE479761T1 (de) 2010-09-15

Family

ID=26916048

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01967946T ATE479761T1 (de) 2000-07-31 2001-07-26 Expression biologisch aktiver polypeptide in wasserlinse

Country Status (14)

Country Link
US (4) US6815184B2 (de)
EP (1) EP1305437B1 (de)
JP (1) JP4795619B2 (de)
CN (2) CN101676400A (de)
AT (1) ATE479761T1 (de)
AU (2) AU8822601A (de)
CA (1) CA2417415C (de)
CY (1) CY1110959T1 (de)
DE (1) DE60142971D1 (de)
DK (1) DK1305437T3 (de)
HK (1) HK1055317A1 (de)
NZ (1) NZ523912A (de)
PT (1) PT1305437E (de)
WO (1) WO2002010414A2 (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL155588A0 (en) * 2003-04-27 2003-11-23 Metabogal Ltd Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby
US20050032211A1 (en) * 1996-09-26 2005-02-10 Metabogal Ltd. Cell/tissue culturing device, system and method
US7161064B2 (en) * 1997-08-12 2007-01-09 North Carolina State University Method for producing stably transformed duckweed using microprojectile bombardment
WO1999019497A1 (en) 1997-10-10 1999-04-22 Yeda Research And Development Co. Ltd. Transgenic lemnaceae
US7959910B2 (en) * 2000-07-31 2011-06-14 Biolex Therapeutics, Inc. C-terminally truncated interferon alpha variants
US8022270B2 (en) * 2000-07-31 2011-09-20 Biolex Therapeutics, Inc. Expression of biologically active polypeptides in duckweed
US7632983B2 (en) 2000-07-31 2009-12-15 Biolex Therapeutics, Inc. Expression of monoclonal antibodies in duckweed
US6815184B2 (en) * 2000-07-31 2004-11-09 Biolex, Inc. Expression of biologically active polypeptide in duckweed
US20030100945A1 (en) 2001-11-23 2003-05-29 Mindguard Ltd. Implantable intraluminal device and method of using same in treating aneurysms
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
US20100196345A1 (en) * 2003-04-27 2010-08-05 Protalix Production of high mannose proteins in plant culture
US7951557B2 (en) 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
US7176024B2 (en) * 2003-05-30 2007-02-13 Biolex, Inc. Bioreactor for growing biological materials supported on a liquid surface
TR201809892T4 (tr) 2003-11-05 2018-07-23 Roche Glycart Ag Fc reseptörüne bağlanma afinitesi ve artırılmış efektör fonksiyonu bulunan antijen bağlayan moleküller.
NZ549537A (en) * 2004-02-11 2009-09-25 Biolex Therapeutics Inc Expression of plasminogen and microplasminogen in duckweed
US7527947B2 (en) 2004-06-14 2009-05-05 Novozymes A/S Signal peptide for producing a polypeptide
DK1756273T3 (da) * 2004-06-14 2010-02-01 Novozymes As Signalpeptid til frembringelse af et polypeptid
US20060024272A1 (en) * 2004-07-29 2006-02-02 Large Scale Biology Corporation C-terminally truncated interferon
CN103981190A (zh) 2005-02-07 2014-08-13 罗氏格黎卡特股份公司 结合egfr的抗原结合分子，编码它的载体，及其应用
CN101146909A (zh) * 2005-03-25 2008-03-19 格黎卡特生物技术股份公司 针对MCSP的并且具有增加的Fc受体结合亲和性和效应子功能的抗原结合分子
EP1888649A2 (de) * 2005-05-09 2008-02-20 GlycArt Biotechnology AG Antigen-bindungsmoleküle mit modifizierten fc-regionen und veränderte bindung an fc-rezeptoren
KR101460932B1 (ko) 2005-08-26 2014-11-12 로슈 글리카트 아게 변형된 세포 신호 활성을 가진 개질된 항원 결합 분자
WO2007084672A2 (en) * 2006-01-17 2007-07-26 Medarex, Inc. Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues
US7622573B2 (en) * 2006-01-17 2009-11-24 Biolex, Inc. Expression control elements from the lemnaceae family
AR062223A1 (es) * 2006-08-09 2008-10-22 Glycart Biotechnology Ag Moleculas de adhesion al antigeno que se adhieren a egfr, vectores que los codifican, y sus usos de estas
MX2009002418A (es) 2006-09-05 2009-04-23 Medarex Inc Anticuerpos para las proteinas morfogenicas oseas y receptores de estas y metodos para su uso.
EP2647388A1 (de) 2007-02-16 2013-10-09 Merrimack Pharmaceuticals, Inc. Antikörper gegen ERBB3 und Verwendungen davon
EP2150608B1 (de) 2007-05-07 2017-11-29 Protalix Ltd. Grossvolumiger einweg-bioreaktor
WO2009015336A2 (en) * 2007-07-25 2009-01-29 Biolex Therapeutics, Inc. Controlled release interferon drug products and treatment of hcv infection using same
EP2225275A4 (de) 2007-11-28 2013-04-03 Medimmune Llc Proteinformulierung
KR101715415B1 (ko) 2008-11-28 2017-03-10 메리얼 인코포레이티드 재조합 조류 인플루엔자 백신 및 그의 용도
EP2398886A2 (de) * 2009-02-18 2011-12-28 Biolex Therapeutics, Inc. Aseptisches bioreaktorsystem zur verarbeitung biologischer materialien
WO2010138631A1 (en) 2009-05-26 2010-12-02 Biolex Therapeutics, Inc. Compositions and methods for production of aglycosylated plasminogen
EP2445336A2 (de) 2009-06-23 2012-05-02 Biolex Therapeutics, Inc. Verfahren und zusammensetzungen für die kryokonservierung von wasserlinsen
WO2011023787A1 (en) 2009-08-31 2011-03-03 Roche Glycart Ag Affinity-matured humanized anti cea monoclonal antibodies
US10633667B2 (en) 2009-12-28 2020-04-28 Boehringer Ingelheim Animal Health USA Inc. Recombinant NDV antigen and uses thereof
RU2575599C2 (ru) 2010-03-12 2016-02-20 Мериал Лимитед Рекомбинантные вакцины против вируса "синего языка", их применение
WO2011140151A1 (en) 2010-05-04 2011-11-10 Dyax Corp. Antibodies against epidermal growth factor receptor (egfr)
WO2012009705A1 (en) 2010-07-15 2012-01-19 Zyngenia, Inc. Ang-2 binding complexes and uses thereof
US20140088019A1 (en) 2011-02-11 2014-03-27 Zyngenia, Inc. Monovalent and Multivalent Multispecific Complexes and Uses Thereof
MX347590B (es) 2011-03-02 2017-05-03 Roche Glycart Ag Anticuerpos del cea.
CN106432506A (zh) 2011-05-24 2017-02-22 泽恩格尼亚股份有限公司 多价和单价多特异性复合物及其用途
US9603906B2 (en) 2012-02-01 2017-03-28 Protalix Ltd. Inhalable liquid formulations of DNase I
US10344296B2 (en) 2012-04-05 2019-07-09 Basf Plant Science Company Gmbh Fungal resistant plants expressing hydrophobin
BR112015021708A2 (pt) 2013-03-06 2017-08-29 Protalix Ltd Inibidor de polipetídeo do tnfa, polinucleotídeo isolado, estrutura de expressão de ácido nucleico, célula de planta, composição farmacêutica e método de produção de um inibidor de polipeptídeo do tnfa
BR112015021707A2 (pt) 2013-03-06 2017-12-05 Hadasit Med Res Service uso de células de planta que expresam um inibidor de polipeptídeo tnfalfa em terapia.
TWI463012B (zh) * 2013-04-01 2014-12-01 Lemnaceae Fermentation Inc 浮萍水解物及其用途
CA2915960A1 (en) 2013-06-17 2014-12-24 Asana Biosciences, Llc 5t4-targeted immunofusion molecule and methods
EP3036322A4 (de) * 2013-08-21 2017-04-12 Cold Spring Harbor Laboratory Transformation von wasserlinsen und verwendungen davon
CN103609304B (zh) * 2013-11-22 2015-08-19 中国科学院成都生物研究所 一种快速提高浮萍淀粉含量的方法
JP6871232B2 (ja) 2015-04-06 2021-05-12 サブドメイン リミテッド ライアビリティ カンパニー 新規結合ドメイン含有ポリペプチドおよびその使用
CA3006759A1 (en) 2015-11-30 2017-06-08 The Regents Of The University Of California Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
JP2019517991A (ja) 2016-03-01 2019-06-27 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 低減したａｄｃｐを有するオビヌツズマブ及びリツキシマブ変異体
IL245102A0 (en) 2016-04-13 2016-07-31 Yeda Res & Dev Cultivation of wolffia plants
AU2018369639A1 (en) 2017-11-14 2020-04-23 Arcellx, Inc. D-domain containing polypeptides and uses thereof
MX2020004935A (es) 2017-11-14 2020-09-25 Arcellx Inc Terapias con celulas inmunitarias multifuncionales.
MX2023001625A (es) 2020-08-07 2023-05-16 Fortis Therapeutics Inc Inmunoconjugados que se dirigen a cd46 y metodos de uso de los mismos.
US20230391829A1 (en) 2020-10-13 2023-12-07 Avitide LLC Aav8 affinity agents
KR20230112616A (ko) 2020-10-13 2023-07-27 아비타이드 엘엘씨 3중-나선 번들 단백질들의 친화성 리간드 라이브러리 및 이의 용도
WO2022178396A1 (en) 2021-02-19 2022-08-25 Avitide LLC Aav2 affinity agents
WO2023122327A2 (en) 2021-12-24 2023-06-29 Avitide LLC Chi domain affinity ligands and agents
WO2024025911A1 (en) 2022-07-29 2024-02-01 Avitide LLC An affinity agent comprising a ligand that binds vce and comprises seq id no: 1

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8315980D0 (en) 1983-06-10 1983-07-13 Biogen Nv Producing hybrid dna sequences
US4956282A (en) 1985-07-29 1990-09-11 Calgene, Inc. Mammalian peptide expression in plant cells
US5256410A (en) * 1988-12-01 1993-10-26 Schering Corporation Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
US5850032A (en) 1992-04-01 1998-12-15 Union Camp Corporation Method for production of plant biological products in precocious neomorphic embryoids
US6288302B1 (en) * 1992-11-04 2001-09-11 National Science Council Of R.O.C. Application of α-amylase gene promoter and signal sequence in the production of recombinant proteins in transgenic plants and transgenic plant seeds
US5569828A (en) 1993-03-24 1996-10-29 Pioneer Hi-Bred International, Inc. Maize chlorotic dwarf virus and resistance thereto
US5780709A (en) * 1993-08-25 1998-07-14 Dekalb Genetics Corporation Transgenic maize with increased mannitol content
US5693506A (en) 1993-11-16 1997-12-02 The Regents Of The University Of California Process for protein production in plants
WO1997004122A1 (en) 1995-07-20 1997-02-06 Washington State University Research Foundation Production of secreted foreign polypeptides in plant cell culture
US6066781A (en) 1997-02-13 2000-05-23 Applied Phytologics, Inc. Production of mature proteins in plants
CA2280894A1 (en) 1997-02-13 1998-08-20 Applied Phytologics, Inc. Production of mature proteins in plants
US6040498A (en) 1998-08-11 2000-03-21 North Caroline State University Genetically engineered duckweed
WO1999007210A1 (en) * 1997-08-12 1999-02-18 North Carolina State University Genetically engineered duckweed
US7161064B2 (en) * 1997-08-12 2007-01-09 North Carolina State University Method for producing stably transformed duckweed using microprojectile bombardment
WO1999019497A1 (en) * 1997-10-10 1999-04-22 Yeda Research And Development Co. Ltd. Transgenic lemnaceae
US6095546A (en) * 1997-12-03 2000-08-01 Tekonsha Engineering Company Trailer hitch cover and accessory components
US6096546A (en) 1998-01-30 2000-08-01 Board Of Trustees, Rutgers, The State University Of New Jersey Methods for recovering polypeptides from plants and portions thereof
EP1064383A2 (de) * 1998-03-19 2001-01-03 Valentis Inc. Interferon-alpha plasmide und applicationssysteme, und methode für ihre herstellung und ihre verwendungen
US6815184B2 (en) * 2000-07-31 2004-11-09 Biolex, Inc. Expression of biologically active polypeptide in duckweed

Also Published As

Publication number Publication date
WO2002010414A3 (en) 2002-12-27
US20120258491A1 (en) 2012-10-11
AU2001288226B2 (en) 2007-07-26
NZ523912A (en) 2005-03-24
US20050060776A1 (en) 2005-03-17
AU8822601A (en) 2002-02-13
CA2417415C (en) 2012-10-09
DK1305437T3 (da) 2010-12-13
CN101676400A (zh) 2010-03-24
EP1305437B1 (de) 2010-09-01
US20090282584A1 (en) 2009-11-12
PT1305437E (pt) 2010-11-12
JP2004504848A (ja) 2004-02-19
CA2417415A1 (en) 2002-02-07
CN1451048A (zh) 2003-10-22
JP4795619B2 (ja) 2011-10-19
WO2002010414A9 (en) 2003-10-30
HK1055317A1 (en) 2004-01-02
WO2002010414A2 (en) 2002-02-07
EP1305437A2 (de) 2003-05-02
DE60142971D1 (de) 2010-10-14
US20020088027A1 (en) 2002-07-04
CY1110959T1 (el) 2015-06-11
US6815184B2 (en) 2004-11-09

Similar Documents

Publication Publication Date Title
ATE479761T1 (de) Expression biologisch aktiver polypeptide in wasserlinse
RU2206611C2 (ru) ФРАГМЕНТ ДНК, ПЛАЗМИДНЫЙ ВЕКТОР, СПОСОБ ПОЛУЧЕНИЯ ПОЛИПЕПТИДА И ПОЛИПЕПТИД, ОБЛАДАЮЩИЙ IL-1β ПРОТЕАЗНОЙ АКТИВНОСТЬЮ
NO20015587D0 (no) Ekspresjon og eksport av interferon-<alfa> proteiner som Fc- fusjonsproteiner
DE60231055D1 (de) Reinigung von peptiden unter verwendung von metall-ion-affinitätschromatographie
FI910960A0 (fi) Dna-fragment, som kodar en polypeptid med nitrilhydratasaktivitet, transformant innehaollande genen och foerfarande foer framstaellning av amiderar med hjaelp av transformanten.
DK1114062T3 (da) Modificeret E. coli-enterotoksin II-signalpeptid og en mikroorganisme, som eksprimerer et fusionsprotein af peptidet og et heterologt protein
NO20014364D0 (no) Ny cytokin-zalphall-ligand
DK1819816T3 (da) Fremgangsmåder til fremstilling og udskillelse af modificerede peptider
BR0111265A (pt) Bacteriocina antilisteria
BR0309401A (pt) polinucleotìdeo isolado, vetor de expressão, célula cultivada, método para produzir polipeptìdeos, e um anticorpo para um polipeptìdeo, e, anticorpo
DK1520860T3 (da) Rekombinant protein PilC, fremgangsmåde til dets fremstilling og anvendelse deraf
ATE452184T1 (de) Mikrobielle trypsinvarianten mit chymotrypsinaktivität und diese codierende nukleinsäuren
ATE334592T1 (de) Biologische bekämpfung von nematoden
NZ296562A (en) Recombinant peptides and secretory mehods for their preparation
DK1546302T3 (da) Fremgangsmåder til fremstilling af pattedyrs-trypsiner
FI953688A (fi) Proteiini, jolla on kasvinsuojelullisia ominaisuuksia
ATE502049T1 (de) Peptide und polypeptide mit verbesserter stabilität, die sich für die regeneration des nervensystems eignen
DK27097A (da) Minactivin og fremgangsmåde til fremstilling deraf
ATE452970T1 (de) N-desoxyribosyltransferase aus lactobacillus, entsprechende nukleinsäuren darauf und ihre verwendungen
DE50109097D1 (de) Promotoren zur genexpression in karyopsen von pflanzen
KR910000180A (ko) 트롬빈 억제 활성을 갖는 폴리펩티드 및 그의 제조방법
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
ATE514710T1 (de) Akap18 delta, eine neue spleissvariante eines proteinkinase a-ankerproteins und verwendung dieser
NO932235L (no) Fremgangsmaate ved fremstilling av syntetiske ledersekvenser
ATE368102T1 (de) Dna-fpr-expression von alpha-i-antitrypsin in methylotropher hefe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1305437

Country of ref document: EP